2009-11-17 07:34:03 -
London, November , 17, 2009
Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------
* Prototypes have already been successfully tested
* The U.S. market launch of automated Cervista systems is
expected in 2010
Männedorf, Switzerland, November 16, 2009 - The Tecan Group (SIX
Swiss Exchange: TECN) today announced a global OEM agreement with
Hologic, Inc., (NASDAQ: HOLX), the women's healthcare company. Under
the agreement, Tecan will supply a fully automated solution for
Hologic's Cervista® molecular diagnostics human papillomavirus (HPV)
tests. The system is based on Tecan's flexible and reliable Freedom
EVO® liquid handling platform with an integrated Tecan detection
device. Prototypes of the automated solution have already been
successfully tested with select Hologic customers.. Validation units
to be used to generate the necessary data for regulatory approval of
the automated system in the U.S. will be supplied before the end of
2009. Tecan expects to ship commercial quantities for Hologic
starting in 2010. Tecan will also supply Hologic with plastic
consumables as an integral part of the validated system. Financial
details were not disclosed.
About Human Papillomavirus and Cervical Cancer
HPV is the most common sexually transmitted disease in the United
States and is recognized as the cause of most cervical cancers. To
help prevent the onset of disease, the American College of Obstetrics
and Gynecology (ACOG) suggests routine Pap and HPV testing for women
over the age of 30 to identify women most likely to develop cervical
cancer.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of
premium diagnostics products, medical imaging systems and surgical
products dedicated to serving the healthcare needs of women.
Hologic's core business units are focused on breast health,
diagnostics, GYN surgical, and skeletal health.
Hologic, Cervista, are trademarks and/or registered trademarks of
Hologic, Inc. and/or its subsidiaries in the United States and/or
other countries.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory
instruments and solutions for the biopharma, forensic and diagnostic
industries. The company specializes in the development, production
and distribution of automation solutions for laboratories in the life
sciences sector. With its subsidiary REMP (www.remp.com), Tecan is
the market leader in automated laboratory storage and logistics
systems. Its clients include pharmaceutical and biotechnology
companies, university research departments and diagnostic
laboratories. Founded in Switzerland in 1980, the company has
manufacturing, research and development sites in both North America
and Europe and maintains a sales and service network in 52 countries.
In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million;
EUR 250.7 million). Registered shares of Tecan Group are traded on
the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security
number: 1210019). TECZn.S / Valor: 1210019).
For further information:
Tecan Group
Martin Brändle
Head of Corporate Communications &
Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
hugin.info/100384/R/1355319/328947.pdf
--- End of Message ---
Tecan Group AG
Seestrasse 103 Männedorf Switzerland
ISIN:
CH0012100191; Index: SBIOM, SLIFE, SMCI, SPI, SPIEX;
Listed: Main Market in SIX Swiss Exchange;
